Pfizer Jury Told Zoloft Risks Known But Hidden From Patients
This article is for subscribers only.
Pfizer Inc. failed to properly warn about its Zoloft antidepressant’s health risks even though internal reports noted some women who took the drug produced babies with birth defects, jurors were told at the end of the first trial of more than 1,000 lawsuits over the drug.
Pfizer’s internal reviews found links between Zoloft and heart abnormalities in babies but the company didn’t update the drug’s U.S. safety label to alert doctors and patients, Shelley Hutson, a lawyer for a family suing the company, said Friday in closing arguments in St. Louis state court.